Roche says new MS drug shown to reduce brain lesions https://ift.tt/FIfBrSb

The Swiss drugmaker said that its fenebrutinib pill significantly reduced brain lesions in people suffering from relapsing forms of multiple sclerosis when compared to a group of patients on placebo, meeting the phase II trial's primary goal.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/2zT9v4N
Share:

No comments:

Post a Comment

Search This Blog

Powered by Blogger.

Labels

Labels

Blog Archive

Recent Posts

Unordered List

  • Lorem ipsum dolor sit amet, consectetuer adipiscing elit.
  • Aliquam tincidunt mauris eu risus.
  • Vestibulum auctor dapibus neque.

Pages

Theme Support

Need our help to upload or customize this blogger template? Contact me with details about the theme customization you need.